A citation-based method for searching scientific literature

Victoria Wykes, Athanasios Zisakis, Mihaela Irimia, Ismail Ughratdar, Vijay Sawlani, Colin Watts. J Neurol Surg A Cent Eur Neurosurg 2021
Times Cited: 10







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Timothy J Brown, Matthew C Brennan, Michael Li, Ephraim W Church, Nicholas J Brandmeir, Kevin L Rakszawski, Akshal S Patel, Elias B Rizk, Dima Suki, Raymond Sawaya,[...]. JAMA Oncol 2016
450
70

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
50

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
40

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
M Lacroix, D Abi-Said, D R Fourney, Z L Gokaslan, W Shi, F DeMonte, F F Lang, I E McCutcheon, S J Hassenbusch, E Holland,[...]. J Neurosurg 2001
40

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
Annette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, Jacob Young, Seunggu J Han, Pranathi Chunduru, Yalan Zhang, Joanna J Phillips, Anny Shai, Marisa Lafontaine,[...]. JAMA Oncol 2020
161
30

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Michael Weller, Martin van den Bent, Matthias Preusser, Emilie Le Rhun, Jörg C Tonn, Giuseppe Minniti, Martin Bendszus, Carmen Balana, Olivier Chinot, Linda Dirven,[...]. Nat Rev Clin Oncol 2021
321
30

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.
Walter Stummer, Hanns-Jürgen Reulen, Thomas Meinel, Uwe Pichlmeier, Wiebke Schumacher, Jörg-Christian Tonn, Veit Rohde, Falk Oppel, Bernd Turowski, Christian Woiciechowsky,[...]. Neurosurgery 2008
669
30

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
30

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
R Stupp, M Brada, M J van den Bent, J-C Tonn, G Pentheroudakis. Ann Oncol 2014
370
30

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim Peter Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf-Dieter Kortmann, Dietmar Krex, Oliver Grauer,[...]. Lancet 2019
235
30

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Walter Stummer, Uwe Pichlmeier, Thomas Meinel, Otmar Dieter Wiestler, Friedhelm Zanella, Hans-Jürgen Reulen. Lancet Oncol 2006
30

An extent of resection threshold for newly diagnosed glioblastomas.
Nader Sanai, Mei-Yin Polley, Michael W McDermott, Andrew T Parsa, Mitchel S Berger. J Neurosurg 2011
945
30

Impact of intraoperative stimulation mapping on high-grade glioma surgery outcome: a meta-analysis.
Jasper Kees Wim Gerritsen, Lidia Arends, Markus Klimek, Clemens Maria Franciscus Dirven, Arnaud Jean-Pierre Edouard Vincent. Acta Neurochir (Wien) 2019
41
30

Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
F-W Kreth, N Thon, M Simon, M Westphal, G Schackert, G Nikkhah, B Hentschel, G Reifenberger, T Pietsch, M Weller,[...]. Ann Oncol 2013
135
20

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Patrick Y Wen, David R Macdonald, David A Reardon, Timothy F Cloughesy, A Gregory Sorensen, Evanthia Galanis, John Degroot, Wolfgang Wick, Mark R Gilbert, Andrew B Lassman,[...]. J Clin Oncol 2010
20

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.
Jörg Felsberg, Niklas Thon, Sabina Eigenbrod, Bettina Hentschel, Michael C Sabel, Manfred Westphal, Gabriele Schackert, Friedrich Wilhelm Kreth, Torsten Pietsch, Markus Löffler,[...]. Int J Cancer 2011
222
20

Glioma extent of resection and its impact on patient outcome.
Nader Sanai, Mitchel S Berger. Neurosurgery 2008
824
20

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Kaisorn L Chaichana, Ignacio Jusue-Torres, Rodrigo Navarro-Ramirez, Shaan M Raza, Maria Pascual-Gallego, Aly Ibrahim, Marta Hernandez-Hermann, Luis Gomez, Xiaobu Ye, Jon D Weingart,[...]. Neuro Oncol 2014
286
20


The epidemiology of glioma in adults: a "state of the science" review.
Quinn T Ostrom, Luc Bauchet, Faith G Davis, Isabelle Deltour, James L Fisher, Chelsea Eastman Langer, Melike Pekmezci, Judith A Schwartzbaum, Michelle C Turner, Kyle M Walsh,[...]. Neuro Oncol 2014
20

Recurrence Pattern Analysis of Primary Glioblastoma.
Marion Rapp, Jessica Baernreuther, Bernd Turowski, Hans-Jakob Steiger, Michael Sabel, Marcel A Kamp. World Neurosurg 2017
42
20

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Roger Stupp, Sophie Taillibert, Andrew Kanner, William Read, David Steinberg, Benoit Lhermitte, Steven Toms, Ahmed Idbaih, Manmeet S. Ahluwalia, Karen Fink,[...]. JAMA 2017
952
20

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
20

5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Philippe Schucht, Sonja Knittel, Johannes Slotboom, Kathleen Seidel, Michael Murek, Astrid Jilch, Andreas Raabe, Jürgen Beck. Acta Neurochir (Wien) 2014
83
20

5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
Michael Müther, Raphael Koch, Matthias Weckesser, Peter Sporns, Wolfram Schwindt, Walter Stummer. Neurosurgery 2019
26
20

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Maarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, Winand N M Dinjens, Peggy N Atmodimedjo, Johan M Kros, Marion Smits, Renske Gahrmann, Geert-Jan Rutten, Jeroen B Verheul,[...]. Neuro Oncol 2018
147
20

Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.
W Stummer, S Stocker, S Wagner, H Stepp, C Fritsch, C Goetz, A E Goetz, R Kiefmann, H J Reulen. Neurosurgery 1998
461
20

Extent of Resection in Glioma-A Review of the Cutting Edge.
Randy S D'Amico, Zachary K Englander, Peter Canoll, Jeffrey N Bruce. World Neurosurg 2017
87
20

Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme.
M R Guilfoyle, R A Weerakkody, A Oswal, I Oberg, C Jeffery, K Haynes, P J Kullar, D Greenberg, S J Jefferies, F Harris,[...]. Br J Cancer 2011
29
20

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
Michael Weller, Martin van den Bent, Kirsten Hopkins, Jörg C Tonn, Roger Stupp, Andrea Falini, Elizabeth Cohen-Jonathan-Moyal, Didier Frappaz, Roger Henriksson, Carmen Balana,[...]. Lancet Oncol 2014
484
20


Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings.
P Mukherjee, J I Berman, S W Chung, C P Hess, R G Henry. AJNR Am J Neuroradiol 2008
293
20

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2020
643
20

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.
Christian Senft, Andrea Bink, Kea Franz, Hartmut Vatter, Thomas Gasser, Volker Seifert. Lancet Oncol 2011
497
20

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree, Dominique Figarella-Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger,[...]. Neuro Oncol 2021
20

Glioblastoma.
Hans-Georg Wirsching, Evanthia Galanis, Michael Weller. Handb Clin Neurol 2016
169
20


Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D?
Mary F Dempsey, Barrie R Condon, Donald M Hadley. AJNR Am J Neuroradiol 2005
93
10


Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.
Niklas Thon, Sabina Eigenbrod, Eva M Grasbon-Frodl, Juergen Lutz, Simone Kreth, Gabriele Popperl, Claus Belka, Hans A Kretzschmar, Joerg-Christian Tonn, Friedrich W Kreth. J Neurol Neurosurg Psychiatry 2011
40
10

The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
Maryam Rahman, Joseph Abbatematteo, Edward K De Leo, Paul S Kubilis, Sasha Vaziri, Frank Bova, Elias Sayour, Duane Mitchell, Alfredo Quinones-Hinojosa. J Neurosurg 2017
87
10

Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.
Christian Hartmann, Bettina Hentschel, Matthias Simon, Manfred Westphal, Gabriele Schackert, Jörg C Tonn, Markus Loeffler, Guido Reifenberger, Torsten Pietsch, Andreas von Deimling,[...]. Clin Cancer Res 2013
113
10

Long-term survival with glioblastoma multiforme.
Dietmar Krex, Barbara Klink, Christian Hartmann, Andreas von Deimling, Torsten Pietsch, Matthias Simon, Michael Sabel, Joachim P Steinbach, Oliver Heese, Guido Reifenberger,[...]. Brain 2007
585
10

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta,[...]. Cell 2016
10

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.
Monika E Hegi, Els Genbrugge, Thierry Gorlia, Roger Stupp, Mark R Gilbert, Olivier L Chinot, L Burt Nabors, Greg Jones, Wim Van Criekinge, Josef Straub,[...]. Clin Cancer Res 2019
63
10

Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery.
Walter Stummer, Thomas Meinel, Christian Ewelt, Peter Martus, Olga Jakobs, Jörg Felsberg, Guido Reifenberger. J Neurooncol 2012
105
10

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
Alireza Mansouri, Laureen D Hachem, Sheila Mansouri, Farshad Nassiri, Normand J Laperriere, Daniel Xia, Neal I Lindeman, Patrick Y Wen, Arnab Chakravarti, Minesh P Mehta,[...]. Neuro Oncol 2019
103
10

Advances in the molecular genetics of gliomas - implications for classification and therapy.
Guido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, Michael Weller. Nat Rev Clin Oncol 2017
335
10

MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Theophilos Tzaridis, Niklas Schäfer, Johannes Weller, Joachim-Peter Steinbach, Uwe Schlegel, Sabine Seidel, Michael Sabel, Peter Hau, Clemens Seidel, Dietmar Krex,[...]. Int J Cancer 2021
4
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.